Cargando…
Racial, Ethnic, and Socioeconomic Inequities in Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Diabetes in the US
IMPORTANCE: Randomized clinical trials have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) cause significant weight loss and reduce cardiovascular events in patients with type 2 diabetes (T2D). Black patients have a disproportionate burden of obesity and cardiovascular disease and...
Autores principales: | Eberly, Lauren A., Yang, Lin, Essien, Utibe R., Eneanya, Nwamaka D., Julien, Howard M., Luo, Jing, Nathan, Ashwin S., Khatana, Sameed Ahmed M., Dayoub, Elias J., Fanaroff, Alexander C., Giri, Jay, Groeneveld, Peter W., Adusumalli, Srinath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796881/ https://www.ncbi.nlm.nih.gov/pubmed/35977298 http://dx.doi.org/10.1001/jamahealthforum.2021.4182 |
Ejemplares similares
-
Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US
por: Eberly, Lauren A., et al.
Publicado: (2021) -
Racial, Ethnic, and Socioeconomic Inequities in Access to Left Atrial Appendage Occlusion
por: Reddy, Kriyana P., et al.
Publicado: (2023) -
Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease
por: Dayoub, Elias J., et al.
Publicado: (2021) -
Racial/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation
por: Eberly, Lauren A., et al.
Publicado: (2021) -
Predictors of telemedicine use during the COVID-19 pandemic in the United States–an analysis of a national electronic medical record database
por: Khatana, Sameed Ahmed M., et al.
Publicado: (2022)